scholarly article | Q13442814 |
P2093 | author name string | P. Taylor | |
D. M. Quinn | |||
S. Camp | |||
Z. Radić | |||
D. C. Vellom | |||
P2860 | cites work | Molecular Pharmacology | Q1943386 |
A new and rapid colorimetric determination of acetylcholinesterase activity | Q26778487 | ||
Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants | Q28183415 | ||
Atomic Structure of Acetylcholinesterase from Torpedo californica : A Prototypic Acetylcholine-Binding Protein | Q28247386 | ||
Two conformational states of Candida rugosa lipase | Q36278235 | ||
Structure and dynamics of the active site gorge of acetylcholinesterase: synergistic use of molecular dynamics simulation and X-ray crystallography | Q36278610 | ||
Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis | Q37299097 | ||
Current view on the structure-function relationship of postsynaptic neurotoxins from snake venoms | Q39691848 | ||
Amino acid residues controlling reactivation of organophosphonyl conjugates of acetylcholinesterase by mono- and bisquaternary oximes | Q41359064 | ||
Theoretical analysis of the structure of the peptide fasciculin and its docking to acetylcholinesterase | Q41828633 | ||
Three distinct domains in the cholinesterase molecule confer selectivity for acetyl- and butyrylcholinesterase inhibitors | Q46263827 | ||
Spectroscopic studies on acetylcholinesterase: influence of peripheral-site occupation on active-center conformation | Q47651634 | ||
Ligand-induced conformational changes in acetylcholinesterase investigated with fluorescent phosphonates | Q47653140 | ||
Chimeric human cholinesterase. Identification of interaction sites responsible for recognition of acetyl- or butyrylcholinesterase-specific ligands | Q49127377 | ||
Effective charge on acetylcholinesterase active sites determined from the ionic strength dependence of association rate constants with cationic ligands. | Q52757699 | ||
Open "back door" in a molecular dynamics simulation of acetylcholinesterase. | Q54032280 | ||
Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states | Q56602329 | ||
Anticholinesterase toxins | Q69809275 | ||
Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity | Q70526231 | ||
Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs | Q72061964 | ||
Residues important for folding and dimerisation of recombinant Torpedo californica acetylcholinesterase | Q72385458 | ||
Enzyme inhibition in relation to chemotherapy | Q80614382 | ||
P433 | issue | 35 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | protein secondary structure | Q904984 |
P304 | page(s) | 20391-20399 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Allosteric control of acetylcholinesterase catalysis by fasciculin | |
Allosteric Control of Acetylcholinesterase Catalysis by Fasciculin | |||
P478 | volume | 270 |
Q32041967 | 125I-labeled fasciculin 2: a new tool for quantitation of acetylcholinesterase densities at synaptic sites by EM-autoradiography |
Q40152460 | A modular treatment of molecular traffic through the active site of cholinesterase |
Q36852533 | A novel role for synaptic acetylcholinesterase as an apoptotic deoxyribonuclease |
Q28546253 | A wrench in the works of human acetylcholinesterase: soman induced conformational changes revealed by molecular dynamics simulations |
Q73424853 | Acetylcholinesterases from Elapidae snake venoms: biochemical, immunological and enzymatic characterization |
Q41167486 | Aging of phosphylated human acetylcholinesterase: catalytic processes mediated by aromatic and polar residues of the active centre |
Q78122907 | Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline |
Q27733273 | Crystal structure of an acetylcholinesterase-fasciculin complex: interaction of a three-fingered toxin from snake venom with its target |
Q35121269 | Crystal structure of snake venom acetylcholinesterase in complex with inhibitory antibody fragment Fab410 bound at the peripheral site: evidence for open and closed states of a back door channel |
Q42552957 | Design, expression and characterization of mutants of fasciculin optimized for interaction with its target, acetylcholinesterase |
Q74615783 | Electron paramagnetic resonance reveals altered topography of the active center gorge of acetylcholinesterase after binding of fasciculin to the peripheral site |
Q46577646 | Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin |
Q88802505 | Erythrocyte acetylcholinesterase as biomarker of pesticide exposure: new and forgotten insights |
Q46648596 | Expression and activity of mutants of fasciculin, a peptidic acetylcholinesterase inhibitor from mamba venom. |
Q34180793 | Finite element simulations of acetylcholine diffusion in neuromuscular junctions |
Q52572224 | Homology built model of acetylcholinesterase from Drosophila melanogaster. |
Q46584907 | In vivo regulation of acetylcholinesterase insertion at the neuromuscular junction |
Q43991996 | Inhibition of acetylcholinesterase from Electrophorus electricus (L.) by tricyclic antidepressants. |
Q44491198 | Inhibition of cholinesterases with cationic phosphonyl oximes highlights distinctive properties of the charged pyridine groups of quaternary oxime reactivators |
Q50156047 | Inhibition of mouse acetylcholinesterase by fasciculin: crystal structure of the complex and mutagenesis of fasciculin |
Q52690659 | Insights into substrate and product traffic in the Drosophila melanogaster acetylcholinesterase active site gorge by enlarging a back channel. |
Q40848338 | Interaction kinetics of reversible inhibitors and substrates with acetylcholinesterase and its fasciculin 2 complex |
Q27680420 | Molecular characterization of monoclonal antibodies that inhibit acetylcholinesterase by targeting the peripheral site and backdoor region |
Q41682084 | Molecular dynamics of mouse acetylcholinesterase complexed with huperzine A. |
Q91994595 | Multi-Target β-Protease Inhibitors from Andrographis paniculata: In Silico and In Vitro Studies |
Q74620314 | Organophosphorylation of acetylcholinesterase in the presence of peripheral site ligands. Distinct effects of propidium and fasciculin |
Q40884310 | Probing the active center gorge of acetylcholinesterase by fluorophores linked to substituted cysteines |
Q30478048 | Protein complex formation by acetylcholinesterase and the neurotoxin fasciculin-2 appears to involve an induced-fit mechanism |
Q43715898 | Reversibly bound and covalently attached ligands induce conformational changes in the omega loop, Cys69-Cys96, of mouse acetylcholinesterase |
Q53987467 | Site-directed mutants designed to test back-door hypotheses of acetylcholinesterase function. |
Q36279762 | Soluble monomeric acetylcholinesterase from mouse: expression, purification, and crystallization in complex with fasciculin. |
Q27640254 | Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site |
Q46097771 | Synaptic currents generated by neuronal acetylcholine receptors sensitive to alpha-bungarotoxin |
Q93146100 | The structural and biochemical impacts of monomerizing human acetylcholinesterase |
Q53285950 | [Exploring the conformational energy landscape of acetylcholinesterase by kinetic crystallography] |
Search more.